Tag - ERNA

Feature

Ernexa moving a scalable, off-the-shelf cell therapy platform toward the clinic

Ernexa Therapeutics (NASDAQ: ERNA) is developing engineered cell therapies designed to modulate the immune system and address significant unmet needs in cancer and autoimmune disease. The company aims to advance its...

November 3, 2026

Developments

Ernexa chosen as one of ten for JETRO acceleration program

Ernexa Therapeutics (NASDAQ: ERNA) has announced it was selected as one of only ten global companies to participate in the prestigious Japan Entry Acceleration Program (JEAP) by the Japan External Trade Organization...

January 27, 2026

Executive Moves

Dr. Elena Ratner joins Eterna’s BOD

Eterna Therapeutics (NASDAQ:ERNA) has announced the appointment of Elena Ratner, MD, MBA, to its board of directors. The company states that Dr. Ratner will spearhead the strategic direction of Eterna’s efforts to...

January 9, 2025

Tag - ERNA

Ernexa moving a scalable, off-the-shelf cell therapy platform toward the clinic

Ernexa chosen as one of ten for JETRO acceleration program

Dr. Elena Ratner joins Eterna’s BOD

Subscribe